WP-1833

Abstract: A drug is provided with an emulsifier and additive free fatty acid compound, and steroids. The fatty compound has a core structure similar to stratum corneum. In one embodiment, the fatty compound includes 75-85 wt% of aqua, 35-45 wt% of caprylic/capric triglyceride, 1-10 wt% of pentylene glycol, 1-9% of hydrogenated lecithin, 1-9% of butyrospermum parkii butter, 1-7 wt% of glycerin, 1-5 wt % of ceramide NP, and 1,2-2,2 wt% of squalene.